WO2026110117 - METHODS AND COMPOSITIONS FOR SHIFTING THE IMMUNOPEPTIDOME OF CANCER CELLS

National phase entry is expected:
Publication Number WO/2026/110117
Publication Date 28.05.2026
International Application No. PCT/IB2025/062008
International Filing Date 24.11.2025
Title **
[English] METHODS AND COMPOSITIONS FOR SHIFTING THE IMMUNOPEPTIDOME OF CANCER CELLS
[French] PROCÉDÉS ET COMPOSITIONS DESTINÉS À MODIFIER L'IMMUNOPEPTIDOME DE CELLULES CANCÉREUSES
Applicants **
DANA-FARBER CANCER INSTITUTE, INC.
Inventors
REINHERZ, Ellis Leonard
BARBIE, David
HARATANI, Koji
PARKINS, Andrew
REINHOLD, Bruce
Priority Data
63/724,620   25.11.2024   US
63/850,062   24.07.2025   US
63/902,799   21.10.2025   US
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting3638
EPO Filing, Examination, Granting26562
Japan Filing, Examination, Granting3139
South Korea Filing, Examination, Granting4148
USA Filing, Examination, Granting11790
MasterCard Visa
Total: 49,277
Contact Us
Abstract[English] Methods and compositions for inducing an immunopeptidome shift in a tumor cell are provided. Such methods and compositions are useful for eliciting an immune response against the tumor cell.[French] L'invention concerne des procédés et des compositions destinées à induire une modification de l'immunopeptidome dans une cellule tumorale. De tels procédés et compositions sont utiles pour déclencher une réponse immunitaire contre la cellule tumorale.